F12
F12 (coagulation factor XII, formerly Hageman factor) is a secreted serum glycoprotein that circulates as a zymogen and, once activated, acts as a serine protease. It participates in the initiation of blood coagulation, fibrinolysis and the generation of bradykinin and angiotensin. Browse Assay Genie's current range of F12 research reagents below, or read on for the biology behind the target.
F12 encodes coagulation factor XII, a serum glycoprotein that takes part in the initiation of blood coagulation, fibrinolysis, and the generation of bradykinin and angiotensin. It is activated through a cascade of cleavages. Prekallikrein is cleaved by factor XII to form kallikrein, which then cleaves factor XII first to alpha-factor XIIa and then to beta-factor XIIa. The active enzyme, factor XIIa, activates coagulation factors VII and XI, placing it near the start of the coagulation cascade.
The F12 gene product circulates in blood as a single-chain zymogen, which is converted to a two-chain serine protease made up of a heavy chain (alpha-factor XIIa) and a light chain. The heavy chain contains two fibronectin-type domains, two epidermal growth factor (EGF)-like domains, a kringle domain and a proline-rich domain, whereas the light chain contains only the catalytic domain. On activation, further cleavage in the heavy chain produces the beta-factor XIIa light chain, and the alpha-factor XIIa light chain becomes the beta-factor XIIa heavy chain. The protein belongs to the peptidase S1 family and is classed by HGNC among serine proteases, kringle domain containing proteins and coagulation factors. Mouse and rat both carry an F12 ortholog.
Factor XII was formerly known as Hageman factor. According to the NCBI Gene summary, defects in this gene do not cause any clinical symptoms, and the sole effect is a prolonged whole-blood clotting time. This makes F12 a useful reference point for studying contact activation, the kallikrein system and the links between coagulation and bradykinin generation.
Factor XIIa activates factors VII and XI, so F12 is studied as an initiating step of the coagulation cascade.
F12 participates in fibrinolysis, making it relevant to work on how clot formation and breakdown are coordinated.
Activated factor XII contributes to the generation of bradykinin and angiotensin, linking coagulation to vasoactive peptide signalling.
Reciprocal cleavage between factor XII and prekallikrein or kallikrein provides a model for zymogen activation in serine protease cascades.
F12 encodes coagulation factor XII, a serum zymogen that becomes an active serine protease. Factor XIIa participates in the initiation of blood coagulation, fibrinolysis, and the generation of bradykinin and angiotensin, and it activates coagulation factors VII and XI. Check the datasheet of any product for its validated reactivity.
F12 was previously named coagulation factor XII (Hageman factor). The single-chain zymogen is cleaved into alpha-factor XIIa, a two-chain form, and then into beta-factor XIIa, which has its own heavy and light chains. Prekallikrein is cleaved by factor XII to form kallikrein, which cleaves factor XII in turn.
According to the NCBI Gene summary, defects in F12 do not cause clinical symptoms; the only effect is a prolonged whole-blood clotting time. Orthologs named F12 exist in both mouse and rat, so rodent models can be used to study the gene.
Other coagulation factors, kallikrein–kinin system proteins and serine proteases that act alongside factor XII.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P00748; product specifications from Assay Genie datasheets.